Evaluation of Chylothorax Using Dynamic Contrast-Enhanced Magnetic Resonance Lymphangiography After Lung Cancer Surgery
Lymphatic Research and Biology · 2023
DOI: 10.1089/lrb.2022.0039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lymphatic Research and Biology, 2023. Verfasst von Jooae Choe und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Research Institute of Radiology and University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea. Hauptthemen laut MEDLINE: Chylothorax, Lung Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
Background
To determine the role of dynamic contrast-enhanced magnetic resonance lymphangiography (DCMRL) in the management of postoperative chylothorax after lung cancer surgery. Methods and Results: Between July 2017 and November 2021, patients who developed postoperative chylothorax following pulmonary resection and mediastinal lymph node dissection were assessed and those who underwent DCMRL for the evaluation of chyle leak were evaluated. The findings of DCMRL and conventional lymphangiography were compared. The incidence of postoperative chylothorax was 0.9% (50/5587). Among the patients with chylothorax, a total of 22 patients (44.0% [22/50]; mean age, 67.6 ± 7.9 years; 15 men) underwent DCMRL. Treatment outcomes were compared between patients with conservative management ( n = 10) and those with intervention ( n = 12). The patients demonstrated unilateral pleural effusion, ipsilateral to the operation site, and showed right-sided dominance. The most frequent site of thoracic duct injury showing contrast media leakage was visualized at the subcarinal level. No DCMRL-related complication occurred. DCMRL showed comparable performance to conventional lymphangiography in visualizing the central lymphatics, including cisterna chyli (DCMRL vs. conventional lymphangiography, 72.7% vs. 45.5%, p = 0.25) and thoracic duct (90.9% vs. 54.5%, p = 0.13), and in localizing thoracic duct injury (90.9% vs. 54.5%, p = 0.13). On follow-up, the amount of chest tube drainage after lymphatic intervention showed a significant difference over time from that after medical treatment only ( p = 0.02).
Conclusion
DCMRL can provide detailed information about the leak site and the central lymphatic anatomy in patients with chylothorax after lung cancer surgery. The findings of DCMRL can guide subsequent treatment planning for optimal outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology and Research Institute of Radiology and University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
- Department of Thoracic and Cardiovascular Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
ORCID-Profile: Hyun Jung Koo, Yura Ahn
Zitieren
APA
Choe, J., Koo, H. J., Ahn, Y., Lee, G. D., Yang, D. H., Kang, J. W., Lee, J. E., & Shin, J. H. (2023). Evaluation of Chylothorax Using Dynamic Contrast-Enhanced Magnetic Resonance Lymphangiography After Lung Cancer Surgery. Lymphatic Research and Biology. https://doi.org/10.1089/lrb.2022.0039
Vancouver
Choe J, Koo HJ, Ahn Y, Lee GD, Yang DH, Kang JW, et al. Evaluation of Chylothorax Using Dynamic Contrast-Enhanced Magnetic Resonance Lymphangiography After Lung Cancer Surgery. Lymphatic Research and Biology. 2023. doi:10.1089/lrb.2022.0039
BibTeX
@article{Choe2023,
author = {Choe, Jooae and Koo, Hyun Jung and Ahn, Yura and Lee, Geun Dong and Yang, Dong Hyun and Kang, Joon-Won and Lee, Ja Eun and Shin, Ji Hoon},
title = {Evaluation of Chylothorax Using Dynamic Contrast-Enhanced Magnetic Resonance Lymphangiography After Lung Cancer Surgery},
journal = {Lymphatic Research and Biology},
year = {2023},
doi = {10.1089/lrb.2022.0039}
}
EUVIMED